Light Mode
$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
-0.03 (-99.69%) / 6M
Momentum, market sentiment, and recent alerts
IBOGF reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -98.6%.
No alerts for IBOGF in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.